Controversial issues regarding the use of induction chemotherapy for lung cancer.
Induction chemotherapy has been proven to improve survival in patients with Stage IIIA non-small cell lung cancer, and is under investigation for early stage disease. Controversy still exists regarding the choice of chemotherapy regimens, patient selection, and inclusion of radiation therapy.
Atkins
B Zane
BZ
Division of Thoracic Surgery, Duke University Medical Center, Durham, NC 27710, USA. damic001@mc.duke.edu
D'Amico
Thomas A
TA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000601:surgery*; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery*; D020360:Neoadjuvant Therapy